XNK Therapeutics to use generic name evencaleucel for lead candidate ...Middle East

PR Newswire - News
XNK Therapeutics to use generic name evencaleucel for lead candidate
HUDDINGE, Sweden, Sept. 26, 2022 /PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced it will adopt the generic name evencaleucel for its lead candidate targeting multiple myeloma. Evencaleucel was recently recommended by the World Health Organization (WHO) as the International...

Hence then, the article about xnk therapeutics to use generic name evencaleucel for lead candidate was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( XNK Therapeutics to use generic name evencaleucel for lead candidate )

Apple Storegoogle play

Last updated :

Also on site :



Latest News